Market Tracker

08/25 5:41am ET

TG Therapeutics Inc (NASDAQ:TGTX)

6.79
Delayed Data
As of Aug 24
 +0.57 / +9.16%
Today’s Change
5.41
Today|||52-Week Range
15.06
-43.08%
Year-to-Date
No recent news for TG Therapeutics Inc.

Today’s Trading

Previous close6.22
Today’s open6.40
Day’s range6.40 - 7.35
Volume1,552,266
Average volume (3 months)415,108
Market cap$338.7M
Dividend yield--
Data as of 08/24/2016

Growth & Valuation

Earnings growth (last year)+15.85%
Earnings growth (this year)+10.56%
Earnings growth (next 5 years)--
Revenue growth (last year)0.00%
P/E ratioNM
Price/Sales3,573.69
Price/Book3.31

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd-0.07-1.17%
PETXAratana Therapeutics...-0.34-3.61%
ARLZAralez Pharmaceutica...-0.31-5.69%
HSKAHeska Corp-0.68-1.33%
Data as of 08/24/2016

Financials

Next reporting dateNovember 7, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$152.4K
Annual profit (last year)-$62.9M
Net profit margin-41,310.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman, President &
CEO
Michael Sean Weiss
CFO, Secretary, Treasurer &
CAO
Sean A. Power
Corporate headquarters
New York, New York

Forecasts